Especially, AML1/ETO9a, a spliced isoform of AML1/ETO [29], correlates with c-kit overexpression/mutations and indicates poor disease outcome in the FAB-M2 subtype of t(8;21) AML [30]. This evidence concerns the gene RUNX1 and acute myeloid leukemia.